Ankit Desai

Has grant

Associate Professor

Indiana University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Ankit Desai is an Associate Professor at the Indiana University School of Medicine in the United States. His research focuses on pulmonary arterial hypertension and the evaluation of right ventricular function. He has contributed to the field through recent publications exploring Mendelian randomisation analysis and clinical methods for assessing RV function.

Recent Grants

Grant: Close

Pathogenic Role of IL-18 in Sickle Cell Cardiomyopathy and Inducible Ventricular Tachycardia

Open Date: 2017-04-01

Close Date: 2022-03-31

Grant: Close

Imaging & genomic approaches to identify cardiac fibrosis and enhance risk profiles of sickle cell-related sudden death

Open Date: 2014-01-01

Close Date: 2015-12-31

Grant: Close

Genomic Studies in a Rodent Model of Pulmonary Hypertension: A Consomics Approach

Open Date: 2007-07-01

Close Date: 2011-07-31

Articles (4)

BACKGROUND: Pulmonary hypertension (PH) represents an important phenotype in heart failure with preserved ejection fraction (HFpEF). However, management of PH-HFpEF is challenging because mechanisms involved in the regulation of PH-HFpEF remain unclear. METHODS: We used a mass spectrometry–based comparative plasma proteomics approach as a sensitive and comprehensive hypothesis-generating discovery technique to profile proteins in patients with PH-HFpEF and control subjects. We then validated and investigated the role of one of the identified proteins using in vitro cell cultures, in vivo animal models, and independent cohort of human samples. RESULTS: Plasma proteomics identified high protein abundance levels of B2M (β2-microglobulin) in patients with PH-HFpEF. Interestingly, both circulating and skeletal muscle levels of B2M were increased in mice with skeletal muscle SIRT3 (sirtuin-3) deficiency or high-fat diet–induced PH-HFpEF. Plasma and muscle biopsies from a validation cohort of PH-HFpEF patients were found to have increased B2M levels, which positively correlated with disease severity, especially pulmonary capillary wedge pressure and right atrial pressure at rest. Not only did the administration of exogenous B2M promote migration/proliferation in pulmonary arterial vascular endothelial cells but it also increased PCNA (proliferating cell nuclear antigen) expression and cell proliferation in pulmonary arterial vascular smooth muscle cells. Finally, B2m deletion improved glucose intolerance, reduced pulmonary vascular remodeling, lowered PH, and attenuated RV hypertrophy in mice with high-fat diet–induced PH-HFpEF. CONCLUSIONS: Patients with PH-HFpEF display higher circulating and skeletal muscle expression levels of B2M, the magnitude of which correlates with disease severity. Our findings also reveal a previously unknown pathogenic role of B2M in the regulation of pulmonary vascular proliferative remodeling and PH-HFpEF. These data suggest that circulating and skeletal muscle B2M can be promising targets for the management of PH-HFpEF.

Year:

2024

BACKGROUND: The ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), but knowledge about the role of deubiquitinating enzymes in this process is limited. UCHL1 (ubiquitin carboxyl-terminal hydrolase 1), a deubiquitinase, has been shown to reduce AKT1 (AKT serine/threonine kinase 1) degradation, resulting in higher levels. Given that AKT1 is pathological in pulmonary hypertension, we hypothesized that UCHL1 deficiency attenuates PAH development by means of reductions in AKT1. METHODS: Tissues from animal pulmonary hypertension models as well as human pulmonary artery endothelial cells from patients with PAH exhibited increased vascular UCHL1 staining and protein expression. Exposure to LDN57444, a UCHL1-specific inhibitor, reduced human pulmonary artery endothelial cell and smooth muscle cell proliferation. Across 3 preclinical PAH models, LDN57444-exposed animals, Uchl1 knockout rats ( Uchl1 −/− ), and conditional Uchl1 knockout mice ( Tie2Cre-Uchl1 fl/fl ) demonstrated reduced right ventricular hypertrophy, right ventricular systolic pressures, and obliterative vascular remodeling. Lungs and pulmonary artery endothelial cells isolated from Uchl1 −/− animals exhibited reduced total and activated Akt with increased ubiquitinated Akt levels. UCHL1-silenced human pulmonary artery endothelial cells displayed reduced lysine(K)63-linked and increased K48-linked AKT1 levels. RESULTS: Supporting experimental data, we found that rs9321, a variant in a GC-enriched region of the UCHL1 gene, is associated with reduced methylation (n=5133), increased UCHL1 gene expression in lungs (n=815), and reduced cardiac index in patients (n=796). In addition, Gadd45α (an established demethylating gene) knockout mice ( Gadd45α −/− ) exhibited reduced lung vascular UCHL1 and AKT1 expression along with attenuated hypoxic pulmonary hypertension. CONCLUSIONS: Our findings suggest that UCHL1 deficiency results in PAH attenuation by means of reduced AKT1, highlighting a novel therapeutic pathway in PAH.

Year:

2024

Year:

2020

Year:

2020

Collaborators (13)

Jason X.-J. Yuan

Professor

University of California

UNITED STATES
View details

Daniel Flaherty

Associate Professor

Purdue University

UNITED STATES
View details

Yen Chun Charly Lai

Assitant Professor of Medicine

Indiana University

UNITED STATES
View details

Jeffrey R. Jacobson

University of Chicago

UNITED STATES
View details

Joe G.N. Garcia

University of Florida

UNITED STATES
View details

Michael Pauciulo

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Jason H. Karnes

-

UNITED STATES
View details

William Nichols

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Noel Warfel

Associate Professor

Medical University of South Carolina

UNITED STATES
View details

Samisubbu Naidu

Indiana University School of Medicine

UNITED STATES
View details

Julio Duarte

Ohio State University

UNITED STATES
View details

sebastien bonnet

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA
View details

Marc Simon

Professor in Residence

UCSF Medical Center

UNITED STATES
View details